TWEAK与寻常型天疱疮炎症及疾病严重程度相关
研究收集60例新发寻常型天疱疮(PV)患者和55例健康对照的血清,分析抗Dsg抗体、炎症因子和趋化因子与疾病严重程度的相关性,并对9例患者皮损及体外PV细胞模型进行研究。结果发现PV患者血清TWEAK、IL-6、TNF-α及CCL5、CXCL8升高且与病情相关,TWEAK可加重PV IgG诱导的桥粒内吞和炎症反应。
要点
- PV患者血清TWEAK、IL-6、TNF-α及CCL5、CXCL8升高,与疾病严重程度相关。
- PV皮损周边可见中性粒细胞、巨噬细胞和T细胞浸润。
- TWEAK加重PV IgG诱导的角质形成细胞桥粒内吞,提示靶向TWEAK可能治疗PV。
核心结论
- PV患者循环中TWEAK、IL-6、TNF-α及CCL5、CXCL8升高,且与疾病严重程度相关。
- TWEAK参与增强趋化因子表达和细胞黏附损伤,提示靶向TWEAK及炎症因子是PV的潜在治疗方向。
研究设计与样本
- 收集60例新发PV患者和55例健康对照的血清,检测抗Dsg抗体、炎症因子及趋化因子。
- 收集9例PV患者皮损样本,分析局部TWEAK、PV IgG表达和免疫细胞浸润。
- 建立体外PV细胞模型,研究PV IgG、各IgG组分及TWEAK诱导的炎症和细胞黏附损伤。
主要发现
- 新发PV患者血清抗Dsg1抗体水平与Pemphigus Disease Area Index评分及TWEAK、IL-6、TNF-α、CCL5、CXCL8水平呈正相关。
- PV皮损周边区域可见中性粒细胞、巨噬细胞和T细胞浸润。
- 体外实验中TWEAK加重PV IgG组分触发的角质形成细胞桥粒内吞。
- PV IgG组分诱导角质形成细胞TWEAK和CXCL8过表达,IL-6、TNF-α和CCL5通过TWEAK依赖途径上调,放大炎症级联。
临床怎么用
- 检测PV患者血清TWEAK及炎症因子水平可能有助于评估疾病严重程度。
- 靶向TWEAK及其相关炎症因子可能成为PV的潜在治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pemphigus vulgaris (PV) is a severe autoimmune blistering disease characterized by immune inflammatory response imbalance. The role of the proinflammatory cytokine tumour necrosis factor-like weak inducer of apoptosis (TWEAK) in the pathogenesis of PV is unclear. OBJECTIVES: To evaluate the inflammatory status in PV and investigate the role of TWEAK in initiating and exacerbating inflammation, as well as its effects on desmoglein (Dsg) internalization at keratinocyte membranes induced by PV cell models and individual PV IgG components. METHODS: We collected serum samples from 60 patients with new-onset PV and 55 healthy controls, to evaluate correlations between serum anti-Dsg antibody levels and disease severity, inflammatory cytokines [TWEAK, interleukin (IL)-1β, IL-2R, IL-6, IL-10, tumour necrosis factor (TNF)-α] and chemokines (CCL2, CCL5, CXCL8). Subsequently, lesional skin samples from nine patients were collected to analyse local TWEAK, PV IgG expression and immune cell infiltration. Finally, an in vitro PV cell model was established to investigate the inflammatory potential and cell adhesion injury of PV IgG, individual PV IgG components and TWEAK induction. RESULTS: Serum anti-Dsg1 antibody levels in patients with new-onset PV were positively correlated with the Pemphigus Disease Area Index score and levels of inflammatory cytokines (TWEAK, IL-6, TNF-α) and chemokines (CCL5, CXCL8). Furthermore, infiltration of immune cells (neutrophils, macrophages and T cells) was seen in the perilesional areas of skin lesions. In vitro experiments showed that TWEAK exacerbates desmosomal internalization in keratinocytes triggered by PV IgG components. Moreover, PV IgG components induce overexpression of TWEAK and CXCL8 in keratinocytes, whereas IL-6, TNF-α and CCL5 were upregulated via TWEAK-dependent pathways, amplifying inflammatory cascades. CONCLUSIONS: This study found elevated levels of inflammatory cytokines (TWEAK, IL-6, TNF-α) and chemokines (CCL5, CXCL8) in the circulation of patients with PV, which correlated with disease severity. Additionally, localized immune dysregulation involving neutrophils, macrophages and T cells was seen in PV skin lesions. We highlight the involvement of TWEAK in enhancing chemokine expression and cell adhesion injury in PV, which suggests a promising therapeutic avenue targeting TWEAK and inflammatory cytokines in the management of PV. Autoimmune diseases are caused by the immune system mistakenly attacking a person’s own healthy cells and tissues. Pemphigus vulgaris (pronounced ‘pem-fuh-gus vul-gah-ris’) is a rare autoimmune disease. It causes severe blistering of the skin and mucous membranes. Mucous membranes line the mouth, nose, throat, eyes and genital area. A protein called ‘TWEAK’ may be involved in pemphigus vulgaris. How TWEAK contributes to inflammation in the disease is poorly understood. We wanted to find out what role TWEAK has in the disease. We analysed blood and skin samples from 60 patients with the disease. Higher levels of TWEAK and other proteins involved in inflammation were linked to how severe the disease was. High numbers of cells involved in the immune system were found in skin samples from people with the disease. Other experiments found that TWEAK causes some cells to not stick together properly. This could contribute to the blisters found in the disease. We found high levels of proteins involved in inflammation in the blood of patients with pemphigus vulgaris. The higher the levels of these proteins were, the more severe disease they had. A disrupted immune system response was seen in skin samples from patients with the disease. We highlight how TWEAK is involved in increasing inflammation and how cells stick together in the skin. This may help develop new treatments for patients with pemphigus vulgaris.
引用
- Peng X, Ran Y, Wang S, et al. Tumour necrosis factor-like weak inducer of apoptosis (TWEAK) is associated with inflammation and disease severity in pemphigus. Br J Dermatol. 2026. PMID: 41192363. doi:10.1093/bjd/ljaf437
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。